TARIS™ Bladder Drug Delivery System
GPTKB entity
Properties (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:delivers |
therapeutic agents
|
| gptkbp:designedFor |
localized drug delivery
|
| gptkbp:developedBy |
gptkb:TARIS_Biomedical
|
| gptkbp:dividendYield |
improved patient outcomes
|
| gptkbp:enhances |
therapeutic efficacy
|
| gptkbp:facilitates |
patient-specific therapy
|
| gptkbp:hasTheme |
hospitalization
|
| https://www.w3.org/2000/01/rdf-schema#label |
TARIS™ Bladder Drug Delivery System
|
| gptkbp:improves |
patient compliance
|
| gptkbp:integration |
advanced drug formulation
|
| gptkbp:isBasedOn |
nanotechnology
|
| gptkbp:isCompatibleWith |
various chemotherapeutics
|
| gptkbp:isConsidered |
a novel approach
|
| gptkbp:isDesignedFor |
outpatient use
maximize_therapeutic_effect |
| gptkbp:isEvaluatedBy |
clinical effectiveness
|
| gptkbp:isFacilitatedBy |
intravesical instillation
|
| gptkbp:isMarketedAs |
gptkb:TARIS_Biomedical
|
| gptkbp:isPartOf |
innovative cancer therapies
bladder cancer treatment options urology innovations |
| gptkbp:isPromotedBy |
a safe alternative
|
| gptkbp:isRecognizedBy |
medical community
|
| gptkbp:isRecognizedFor |
its effectiveness
|
| gptkbp:isRegardedAs |
a breakthrough technology
|
| gptkbp:isSubjectTo |
regulatory oversight
|
| gptkbp:isSupportedBy |
research funding
clinical evidence |
| gptkbp:isTargetedAt |
bladder tumors
|
| gptkbp:isTestedFor |
safety and efficacy
|
| gptkbp:isTrainedIn |
various trials
|
| gptkbp:isUsedBy |
oncologists
|
| gptkbp:isUsedIn |
clinical settings
|
| gptkbp:isUtilizedIn |
clinical studies
bladder cancer management drug delivery methods |
| gptkbp:isValuedFor |
its precision
|
| gptkbp:isVisitedBy |
improve drug delivery efficiency
oncology applications |
| gptkbp:mayHave |
better quality of life
treatment outcomes |
| gptkbp:offers |
sustained release
|
| gptkbp:oversees |
intravesical therapy
|
| gptkbp:provides |
targeted therapy
customized treatment plans |
| gptkbp:providesAccessTo |
specialized therapies
|
| gptkbp:providesSupportFor |
patients with bladder cancer
|
| gptkbp:reduces |
side effects
systemic exposure |
| gptkbp:supports |
personalized medicine
|
| gptkbp:targets |
urothelium
|
| gptkbp:updates |
drug retention time
|
| gptkbp:usedFor |
bladder cancer treatment
|
| gptkbp:utilizes |
controlled release
biodegradable polymer technology advanced delivery techniques |
| gptkbp:wasAffecting |
2010s
|
| gptkbp:worksOn |
targeting bladder tissue
|